These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2467548)

  • 1. The relationship of nuclear staining density and mode of stromal invasion with axillary metastases and hormone receptor status in human breast cancer.
    Bell CD; Shokry PE; Stadler J
    Am J Clin Pathol; 1989 Apr; 91(4):377-85. PubMed ID: 2467548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of cytoplasmic intermediate filaments and membrane antigens with hormone receptors, nuclear staining density, and mode of stromal invasion in human breast cancer.
    Bell CD; Tischler EM; Laroye GJ
    Breast Cancer Res Treat; 1995; 33(2):147-62. PubMed ID: 7538357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of nuclear appearance to stromal invasion in human breast cancer.
    Bell CD; Stadler J; Michowitz M; Inbar M
    J Surg Oncol; 1987 May; 35(1):63-9. PubMed ID: 3033402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor differentiation and histological type in human breast cancer.
    Bell CD; Stadler J; Waizbard E; Chaitchik S; Greif F
    J Surg Oncol; 1986 Jan; 31(1):39-43. PubMed ID: 3003460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High nuclear grade, frequent mitotic activity, cyclin D1 and p53 overexpression are associated with stromal invasion in mammary intracystic papillary carcinoma.
    Zhang C; Zhang P; Hao J; Quddus MR; Steinhoff MM; Sung CJ
    Breast J; 2005; 11(1):2-8. PubMed ID: 15647071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters.
    Thike AA; Chng MJ; Fook-Chong S; Tan PH
    Pathology; 2001 Feb; 33(1):21-5. PubMed ID: 11280603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor.
    Clayton F
    Cancer; 1991 Sep; 68(6):1309-17. PubMed ID: 1651805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
    Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
    Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
    Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Eur Surg Res; 1992; 24(3):160-8. PubMed ID: 1499604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histology and cytometrics in human breast cancers assayed for the presence of prolactin receptors.
    Codegone ML; Di Carlo R; Muccioli G; Bussolati G
    Tumori; 1981 Dec; 67(6):549-52. PubMed ID: 6278686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors.
    González-Vela MC; Garijo MF; Fernández FA; Buelta L; Val-Bernal JF
    Pathol Res Pract; 1999; 195(9):611-8. PubMed ID: 10507081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tonsillar metastasis from carcinoma of the breast with ultrastructural and steroid receptor analyses.
    Barton TK; Kesterson GH; Wellman D; McCarty KS
    Laryngoscope; 1980 Mar; 90(3):477-85. PubMed ID: 6244468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early (<10 mm) HER2-Positive Invasive Breast Carcinomas are Associated with Extensive Diffuse High-Grade DCIS: Implications for Preoperative Mapping, Extent of Surgical Intervention, and Disease-Free Survival.
    Tot T
    Ann Surg Oncol; 2015 Aug; 22(8):2532-9. PubMed ID: 25582746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of VLA-2 collagen receptor in breast carcinoma, facilitating invasion and metastasis.
    Arihiro K; Inai K; Kurihara K; Takeda S; Kaneko M; Kuroi K; Toge T
    Jpn J Cancer Res; 1993 Jul; 84(7):726-33. PubMed ID: 8396565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 as a prognostic factor in breast cancer.
    Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
    Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.